IE
PACB icon

Israel Englander’s Pacific Biosciences PACB Stock Holding History

Israel Englander’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-50,000
Closed -$62K – 6345
2025
Q2 		$62K Buy
+50,000
New +$57.7K ﹤0.01% 5583
2024
Q4 		– Sell
-198,200
Closed -$337K – 6326
2024
Q3 		$337K Buy
198,200
+48,200
+32% +$79.2K ﹤0.01% 5120
2024
Q2 		$206K Buy
150,000
+100,000
+200% +$202K ﹤0.01% 5130
2024
Q1 		$188K Buy
+50,000
New +$293K ﹤0.01% 5401

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Israel Englander's PACB Position: Q2 2026 in Review

Israel Englander reduced its Pacific Biosciences (PACB) stake by 19% in Q2 2026, selling an estimated $1.35M and leaving 3,962,442 shares worth $6.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2719.

Israel Englander first reported a position in PACB in Q2 2013 and has held it in 51 quarters since. The position peaked at $38.3M in Q4 2020. 222 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Israel Englander held 3,962,442 shares of Pacific Biosciences worth $6.66M as of Q2 2026.
  • Israel Englander sold 929,876 Pacific Biosciences shares in Q2 2026, an estimated $1.35M.
  • Pacific Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2719 holding.
  • Israel Englander first reported a position in Pacific Biosciences in Q2 2013 and has held it in 51 quarters since.
  • Israel Englander's Pacific Biosciences position peaked at $38.3M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.